Most microbial infections are either restricted to the mucosal membranes or
the etiologic agents needed to transit the mucosa. Thus: it is desirable t
o stimulate a mucosal response following vaccination, to block both infecti
on and disease development. Attenuated vaccine carriers mimic natural infec
tions, triggering also mucosal responses. Similar results can be achieved b
y administering antigens with appropriate adjuvants. However, the delivery
of antigens per se is not sufficient to engender a protective response. A s
uccessful immunization requires the elicitation of an appropriate type of i
mmune response (e.g. antibodies vs. cell-mediated immunity, Th1 vs. Th2 hel
per pattern). Therefore, a successful vaccination strategy demands the choi
ce of adequate antigens, and their appropriate delivery and/or formulation
to promote the required quality of immune response. Different strategies to
optimize the immune responses elicited following vaccine administration by
the mucosal route are discussed. (C) 2000 Federation of European Microbiol
ogical Societies. Published by Elsevier Science B.V. All rights reserved.